Reduced bone mineral density in children with hypercalciuria, nephrolithiasis and nephrocalcinosis
https://doi.org/10.21508/1027-4065-2016-61-5-160-165
Abstract
The article presents the results of a examination of 105 children aged 1 to 16 years, 22 of them are diagnosed with nephrocalcinosis, 11 stone in the urinary system amid hypercalciuria, 23 hypercalciuria was observed without the formation of concretions in the urinary system, 49 children with chronic pyelonephritis. In children with hypercalciuria, nephrolithiasis and nephrocalcinosis decreased bone mineral density was observed in 45% of cases, in children with chronic pyelonephritis osteopenia was found in half of the patients (51%). Reduced bone mineral density in children with hypercalciuria increased risk of fractures. In patients with osteopenia two-and three-multiples fractures were observed in 3 times more than the comparison group. Increase both of alkaline phosphatase and acidic phosphatase showed activation of bone metabolism, and proportionality of their activation determined state of bone mineral density. Patients with chronic pyelonephritis with severe osteopenia observed prepotency of processes of bone resorption relative to bone formation.
About the Authors
C. V. Maltsev
Kazan state medical Academy, Kazan
Russian Federation
Russian Federation
T. V. Mikhailova
Kazan state medical Academy, Kazan
Russian Federation
Russian Federation
S. S. Vinokurova
Kazan state medical Academy, Kazan
Russian Federation
Russian Federation
References
1. Arrabal-Polo M.A., Arrabal-Martin M., de Haro-Munoz T. et al. Mineral density and bone remodelling markers in patients with calcium lithiasis. BJU Int 2011; 108: 12: 1903– 1908.
2. Arrabal-Polo M.A., Arrabal-Martin M., Arias-Santiago S. et al. Metabolic-mineral study in patients with renal calcium lithiasis, severe lithogenic activity and loss of bone mineral density. Singapore Med J 2012; 53: 12: 808–813.
3. Aruga S., Honma Y. Renal calcium excretion and urolithiasis. Clin Calcium 2011; 21: 10: 1465–1472.
4. Bijelic R., Milicevic S., Balaban J. Incidence of osteoporosis in patients with urolithiasis. Med Arch 2014; 68: 5: 335–338.
5. Bone mineral density status in urolithiasis patients with vitamin D inadequacy followed at a tertiary stone centre. Canad Urol Ass J 2014; 8: 10: 323–328.
6. Celik A., Davutoglu V., Sakip Erturhan K. et al. Relationship between renal stone formation, mitral annular calcification and bone resorption markers. Ann Saudi Med.2010; 30: 8: 301–305.
7. Длин В.В., Османов И.М., Новиков П.В. и др. Дисмета- болическая нефропатия, мочекаменная болезнь и не- фрокальциноз у детей. М: Оверлей, 2005; 232. (Dlin V.V., Osmanov I.M., Novikov P.V. et al. Dysmetabolic nephropathy, urolithiasis and nephrocalcinosis in children. M: Overlej, 2005; 232. (in Russ))
8. Ryan L.E., Ing S.W. Idiopathic hypercalciuria and bone health. Curr Osteoporos Rep 2012; 10: 4: 286–295.
9. Sakhaee D.K., Maalouf N.M., Kumar R. et al. Nephrolithiasisassociated bone disease: pathogenesis and treatment options. Kidney Int 2011; 79: 2: 393–403.
10. Schwaderer A.L., Cronin R., Mahan J.D. et al. Low bone density in children with hypercalciuria and/or nephrolithiasis. Pediatr Nephrol 2008; 23: 12: 2209–2214.
11. Яровой С.К., Максудов P.P. Нефролитиаз и метаболические остеопатии на фоне соматических заболеваний. Экспер и клин урол 2015; 1: 108–114. (Jarovoj S.K., Maksudov P.P. Nephrolithiasis and metabolic osteopathy at various systemic diseases. Jeksper i klin urol 2015; 1: 108– 114. (in Russ))
12. Moreira Guimarães Penido M.G., de Sousa Tavares M., Campos Linhares M. et al. Longitudinal study of bone mineral density in children with idiopathic hypercalciuria. Pediatr Nephrol 2012; 27: 1: 123–130.
13. Zerwekh J.E. Bone disease and hypercalciuria in children. Pediatr Nephrol 2010; 25: 3: 395–401.
14. Knoll T. Epidemiology, Pathogenesis, and Pathophysiology of Urolithiasis. Eur Urol 2010; 9: 802–806.
15. Romero V., Akpinar H., Assimos D.G. Kidney Stones: A Global Picture of Prevalence, Incidence, and Associated Risk Factors. RevUrol 2010; 12: 2–3: 86–96.
16. Gunes S., Bilen C.Y., Kara N. et al. Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006; 34: 47–52.
17. Dimke H., Desai P., Borovac J. et al. Activation of the Ca (2+) — sensing receptor increases renal claudin-14 expression and urinary Ca (2+) excretion. Am J Physiol Renal Physiol 2013; 304: 6: F761–769.
18. Thorleifsson G., Holm H., Edvardsson V. et al. Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density. Nature Genet 2009; 41: 926–930.
19. Muller D., Kausalya P.J., Bockenhauer D. et al. Unusual clinical presentation and possible rescue of a novel claudin-16 mutation. J Clin Endocr Metab 2006; 91: 3076–3079.
20. Arrabal-Polo M.A., Arias-Santiago S., de Haro-Munoz T. Effects of aminobisphosphonates and thiazides in patients with osteopenia/osteoporosis, hypercalciuria, and recurring renal calcium lithiasis. Urology 2013; 81: 731–737.
21. Bianchi G., Giusti A., Pioli G. Bisphosphonates in the management of idiopathic hypercalciuria associated with osteoporosis: a new trick from an old drug. Ther Adv Musculoskel Dis 2010; 2: 1: 29–35.
22. Смолянский Б.Л. Руководство по лечебному питанию. Л: Медицина 1981; 280. (Smoljanskij B.L. For clinical nutrition guide. L: Meditsina 1981; 280. (in Russ))
23. Покровский А.А., Самсонов М.А. Справочник по дието- логии I. М: Медицина 1981; 701. (Pokrovskij A.A., Samsonov M.A. Handbook of Nutrition I. Moscow: Meditsina 1981; 280. (in Russ))
Review
For citations:
Maltsev C.V., Mikhailova T.V., Vinokurova S.S. Reduced bone mineral density in children with hypercalciuria, nephrolithiasis and nephrocalcinosis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2016;61(5):160-165. (In Russ.) https://doi.org/10.21508/1027-4065-2016-61-5-160-165
Views:
666
Email this article 